Discover 95 paid clinical trials in Huntsville, Alabama. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 95
FeaturedActive & Responsive
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
for
Bipolar Depression
Location: Atlanta GA, Decatur GA, Lawrenceville GA, Dothan AL,
Sponsor: Intra-Cellular Therapies, Inc.
Sex: All
Age: 10 - 17
Code: NCT06372964
Phase3, Recruiting
Active & ResponsiveNew
A Study to Evaluate the Safety and Efficacy of CD388 for Prevention of Influenza
for
Influenza
Location: Cullman AL, Anniston AL, Hendersonville TN, Atlanta GA,
Sponsor: Cidara Therapeutics Inc.
Sex: All
Age: 12+
Code: NCT07159763
Phase3, Recruiting
Active & Responsive
A Study to Explore the Efficacy of JNJ-89495120 in the Treatment of Major Depressive Disorder
for
Depressive Disorder, Major
Location: Huntsville AL, Atlanta GA, Decatur GA, Cincinnati OH,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18 - 64
Code: NCT06785012
Phase2, Recruiting
Active & Responsive
GATE-251 or Placebo for the Reduction of Symptoms of Major Depressive Disorder
Get alerts for new trials in your area by subscribing now
Active & Responsive
An Extension and Crossover Vaccination Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus Given to Adults 60 Years of Age and Above Who Participated in RSV OA=ADJ-006 Study
for
Respiratory Syncytial Virus Infections
Location: Huntsville AL, Birmingham AL, Atlanta GA, Knoxville TN,
Sponsor: GlaxoSmithKline
Sex: All
Age: 60+
Code: NCT06534892
Phase3, Recruiting
Active & Responsive
VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)
Prospective Outcomes Study: Vectra® DA Guided Care Compared to Usual Care
for
Arthritis, Rheumatoid
Location: Huntsville AL, Tupelo MS, Bowling Green KY,
Sponsor: Crescendo Bioscience
Sex: All
Age: 18 - 70+
Code: NCT02832297
Recruiting
Active & Responsive
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression